Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Csernansky

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 15, 1998
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunctionY I Sheline, K Miller, M E Bardgett, et al.
Journal of Clinical Psychopharmacology|December 1, 1984
Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label studyJ G Csernansky, L Lombrozo, G D Gulevich, et al.
Psychiatric Services (Washington, D.C.)|August 26, 1998
Predicting length of stay in an acute psychiatric hospitalD A Huntley, D W Cho, J Christman, et al.
Psychopharmacology|March 14, 1998
The effects of kainic acid lesions on locomotor responses to haloperidol and clozapineM E Bardgett, J L Jackson, B M Taylor, et al.
Psychiatry Research|May 1, 1989
Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patientsW O Faustman, J A Moses, J G Csernansky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 1995
Platelet binding characteristics distinguish placebo responders from nonresponders in depressionY I Sheline, K J Black, M E Bardgett, et al.
Psychopharmacology Bulletin|January 1, 1991
Clinical factors that may confound the assessment of drug efficacyJ G Csernansky, J W Newcomer, L S Miller, et al.
European Journal of Pharmacology|January 19, 1993
Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neurolepticsM E Bardgett, C T Wrona, J W Newcomer, et al.
Behavioural Brain Research|October 1, 1995
Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophreniaM E Bardgett, J L Jackson, G T Taylor, et al.
Psychiatry Research|November 1, 1989
CSF phenylacetic acid and hostility in paranoid schizophreniaK F Faull, R J King, J D Barchas, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 15, 1998
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunctionY I Sheline, K Miller, M E Bardgett, et al.
Journal of Clinical Psychopharmacology|December 1, 1984
Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label studyJ G Csernansky, L Lombrozo, G D Gulevich, et al.
Psychiatric Services (Washington, D.C.)|August 26, 1998
Predicting length of stay in an acute psychiatric hospitalD A Huntley, D W Cho, J Christman, et al.
Psychopharmacology|March 14, 1998
The effects of kainic acid lesions on locomotor responses to haloperidol and clozapineM E Bardgett, J L Jackson, B M Taylor, et al.
Psychiatry Research|May 1, 1989
Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patientsW O Faustman, J A Moses, J G Csernansky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 1995
Platelet binding characteristics distinguish placebo responders from nonresponders in depressionY I Sheline, K J Black, M E Bardgett, et al.
Psychopharmacology Bulletin|January 1, 1991
Clinical factors that may confound the assessment of drug efficacyJ G Csernansky, J W Newcomer, L S Miller, et al.
European Journal of Pharmacology|January 19, 1993
Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neurolepticsM E Bardgett, C T Wrona, J W Newcomer, et al.
Behavioural Brain Research|October 1, 1995
Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophreniaM E Bardgett, J L Jackson, G T Taylor, et al.
Psychiatry Research|November 1, 1989
CSF phenylacetic acid and hostility in paranoid schizophreniaK F Faull, R J King, J D Barchas, et al.
Pageof 14